Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Other Non Operating Income: 2014-2024

Historic Other Non Operating Income for Zevra Therapeutics (ZVRA) over the last 6 years, with Dec 2024 value amounting to $6.2 million.

  • Zevra Therapeutics' Other Non Operating Income rose 2.58% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.9 million, marking a year-over-year increase of 1807.37%. This contributed to the annual value of $6.2 million for FY2024, which is 340.28% up from last year.
  • Per Zevra Therapeutics' latest filing, its Other Non Operating Income stood at $6.2 million for FY2024, which was up 340.28% from $1.4 million recorded in FY2023.
  • Over the past 5 years, Zevra Therapeutics' Other Non Operating Income peaked at $6.2 million during FY2024, and registered a low of -$16.1 million during FY2021.
  • Its 2-year average for Other Non Operating Income is $3.8 million, with a median of $3.8 million in 2023.
  • Data for Zevra Therapeutics' Other Non Operating Income shows a peak YoY spiked of 340.28% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Zevra Therapeutics' Other Non Operating Income stood at -$16.1 million in 2021, then reached $1.4 million in 2023, then spiked by 340.28% to $6.2 million in 2024.